Population
Adults with non-alcoholic fatty liver disease (NAFLD)
Design
Review
Authors
Loading...
NAFLD may warrant CV risk vigilance in practice; leaves open whether targeted therapy improves outcomes.
NAFLD is an independent cardiometabolic risk factor for cardiovascular diseases, highlighting the need for a multidisciplinary treatment approach involving cardiologists.
Garbuzenko et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: